vs
PROSPERITY BANCSHARES INC（PB）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是PROSPERITY BANCSHARES INC的1.7倍（$622.0M vs $367.6M），Royalty Pharma plc净利率更高（34.4% vs 31.6%，领先2.8%），过去两年PROSPERITY BANCSHARES INC的营收复合增速更高（19.2% vs 4.6%）
Prosperity Bancshares Inc.是总部位于美国得克萨斯州休斯顿的银行控股公司，业务覆盖得克萨斯州及俄克拉荷马州中部。截至2019年12月31日，公司共运营285家分支机构，广泛分布在休斯顿、达拉斯-沃斯堡都会区及得州南部、东部、中部、西部等区域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PB vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.7倍
$367.6M
净利率更高
RPRX
高出2.8%
31.6%
两年增速更快
PB
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $367.6M | $622.0M |
| 净利润 | $116.3M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 31.6% | 34.4% |
| 营收同比 | — | 4.8% |
| 净利润同比 | -10.7% | 2.9% |
| 每股收益（稀释后） | $1.16 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBRPRX
| Q1 26 | $367.6M | — | ||
| Q4 25 | $275.0M | $622.0M | ||
| Q3 25 | $273.4M | $609.3M | ||
| Q2 25 | $267.7M | $578.7M | ||
| Q1 25 | $265.4M | $568.2M | ||
| Q4 24 | $267.8M | $593.6M | ||
| Q3 24 | $261.7M | $564.7M | ||
| Q2 24 | $258.8M | $537.3M |
净利润PBRPRX
| Q1 26 | $116.3M | — | ||
| Q4 25 | $139.9M | $214.2M | ||
| Q3 25 | $137.6M | $288.2M | ||
| Q2 25 | $135.2M | $30.2M | ||
| Q1 25 | $130.2M | $238.3M | ||
| Q4 24 | $130.1M | $208.2M | ||
| Q3 24 | $127.3M | $544.0M | ||
| Q2 24 | $111.6M | $102.0M |
营业利润率PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 65.1% | 62.4% | ||
| Q3 25 | 64.4% | 70.1% | ||
| Q2 25 | 64.3% | 36.3% | ||
| Q1 25 | 62.7% | 94.0% | ||
| Q4 24 | 62.0% | 60.9% | ||
| Q3 24 | 62.1% | — | ||
| Q2 24 | 55.2% | 50.2% |
净利率PBRPRX
| Q1 26 | 31.6% | — | ||
| Q4 25 | 50.9% | 34.4% | ||
| Q3 25 | 50.3% | 47.3% | ||
| Q2 25 | 50.5% | 5.2% | ||
| Q1 25 | 49.1% | 41.9% | ||
| Q4 24 | 48.6% | 35.1% | ||
| Q3 24 | 48.6% | 96.3% | ||
| Q2 24 | 43.1% | 19.0% |
每股收益（稀释后）PBRPRX
| Q1 26 | $1.16 | — | ||
| Q4 25 | $1.48 | $0.49 | ||
| Q3 25 | $1.45 | $0.67 | ||
| Q2 25 | $1.42 | $0.07 | ||
| Q1 25 | $1.37 | $0.55 | ||
| Q4 24 | $1.36 | $0.46 | ||
| Q3 24 | $1.34 | $1.21 | ||
| Q2 24 | $1.17 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $8.2B | $9.7B |
| 总资产 | $43.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
股东权益PBRPRX
| Q1 26 | $8.2B | — | ||
| Q4 25 | $7.6B | $9.7B | ||
| Q3 25 | $7.7B | $9.6B | ||
| Q2 25 | $7.6B | $9.5B | ||
| Q1 25 | $7.5B | $9.8B | ||
| Q4 24 | $7.4B | $10.3B | ||
| Q3 24 | $7.4B | $10.3B | ||
| Q2 24 | $7.3B | $9.8B |
总资产PBRPRX
| Q1 26 | $43.6B | — | ||
| Q4 25 | $38.5B | $19.6B | ||
| Q3 25 | $38.3B | $19.3B | ||
| Q2 25 | $38.4B | $18.3B | ||
| Q1 25 | $38.8B | $17.6B | ||
| Q4 24 | $39.6B | $18.2B | ||
| Q3 24 | $40.1B | $18.0B | ||
| Q2 24 | $39.8B | $17.7B |
负债/权益比PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $78.3M | $827.1M | ||
| Q3 25 | $194.8M | $702.6M | ||
| Q2 25 | $98.2M | $364.0M | ||
| Q1 25 | $178.2M | $596.1M | ||
| Q4 24 | $-205.8M | $742.5M | ||
| Q3 24 | $274.6M | $703.6M | ||
| Q2 24 | $216.5M | $658.2M |
自由现金流PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | $68.5M | — | ||
| Q3 25 | $185.7M | — | ||
| Q2 25 | $91.8M | — | ||
| Q1 25 | $171.1M | — | ||
| Q4 24 | $-210.7M | — | ||
| Q3 24 | $270.2M | — | ||
| Q2 24 | $211.8M | — |
自由现金流率PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 24.9% | — | ||
| Q3 25 | 67.9% | — | ||
| Q2 25 | 34.3% | — | ||
| Q1 25 | 64.5% | — | ||
| Q4 24 | -78.7% | — | ||
| Q3 24 | 103.3% | — | ||
| Q2 24 | 81.8% | — |
资本支出强度PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.8% | — |
现金转化率PBRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.56× | 3.86× | ||
| Q3 25 | 1.42× | 2.44× | ||
| Q2 25 | 0.73× | 12.06× | ||
| Q1 25 | 1.37× | 2.50× | ||
| Q4 24 | -1.58× | 3.57× | ||
| Q3 24 | 2.16× | 1.29× | ||
| Q2 24 | 1.94× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
